Olink Holding AB (publ) Convenes EGM, Adopts Resolutions Impacting Life Science Research Services

UPPSALA, Sweden—July 5, 2024—an Extra General Meeting ('EGM') for Olink Holding AB (publ), a leading provider of life science research products and services, was held, where multiple key resolutions were adopted. With its focus on serving academic, government, biopharmaceutical, biotechnology, and other life science research organizations, Olink Holding, registered number 559189-7755, is committed to innovation and excellence in its field.

Summary of EGM Resolutions

During the EGM, shareholders and participants in Olink Holding AB's meeting addressed a series of pivotal decisions. The adopted resolutions play a significant role in the company's governance and strategic direction. Comprehensive details about each resolution can be found in the full report. Shareholders and interested parties keen on the company’s direction are advised to review the decisions made during this meeting, as they are expected to influence the company’s trajectory in the life science industry.

Impact on OLK

The outcomes of these resolutions are poised to have an impact on Olink Holding’s operational efficacy and its commitment to fostering growth within the life science research community. Those invested or interested in the company’s performance, under the ticker OLK, should note these developments.

Investment, Resolution, Meeting